Sale!

ARL6IP1 Gene SPG61 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ARL6IP1 gene, associated with SPG61, is a critical genetic marker for diagnosing hereditary spastic paraplegia type 61 (SPG61), a rare neurodegenerative disorder. This condition is characterized by progressive weakness and spasticity of the lower limbs due to the degeneration of the corticospinal tract neurons. The ARL6IP1 gene plays a significant role in the maintenance and function of the nervous system, and mutations in this gene can lead to the clinical manifestations of SPG61.

To accurately diagnose this condition, a genetic test targeting the ARL6IP1 gene can be conducted. In the UAE, this specialized test is available at DNA Labs UAE, a leading facility in genetic diagnostics. The test involves analyzing the patient’s DNA to identify mutations in the ARL6IP1 gene that are indicative of SPG61. This genetic test is crucial for confirming the diagnosis, understanding the prognosis, and guiding the management and treatment plans for affected individuals.

The cost of the ARL6IP1 gene SPG61 genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect any genetic alterations in the ARL6IP1 gene, providing patients and their families with essential information for managing the condition. Given the complexity of hereditary spastic paraplegia and the importance of early intervention, this genetic test is a valuable tool in the diagnostic process, offering insights that can significantly impact the quality of life of those affected by SPG61.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ARL6IP1 Gene SPG61 Genetic Test

Welcome to DNA Labs UAE, where we offer the ARL6IP1 Gene SPG61 Genetic Test. This test is designed to diagnose a subtype of hereditary spastic paraplegia called SPG61. Hereditary spastic paraplegia is characterized by progressive weakness and stiffness in the lower limbs.

Test Details

The ARL6IP1 (ADP-ribosylation factor-like 6 interacting protein 1) gene is associated with SPG61. To analyze this gene, we use NGS (Next-Generation Sequencing) technology, which allows us to analyze multiple genes simultaneously and identify genetic variations or mutations.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the ARL6IP1 Gene SPG61 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with ARL6IP1 Gene SPG61.

Test Process

The NGS genetic test for ARL6IP1 gene SPG61 involves obtaining a DNA sample, typically through a blood sample or saliva sample, from the individual undergoing testing. The DNA sample is then sequenced using NGS technology to identify any variations or mutations in the ARL6IP1 gene.

Results and Benefits

The results of the NGS genetic test can provide valuable information about the presence or absence of specific mutations in the ARL6IP1 gene associated with SPG61. This information can help in confirming a diagnosis, providing accurate genetic counseling, and guiding treatment options for individuals with SPG61.

Test Name ARL6IP1 Gene SPG61 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ARL6IP1 Gene SPG61 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ARL6IP1 Gene SPG61
Test Details

ARL6IP1 (ADP-ribosylation factor-like 6 interacting protein 1) is a gene that is associated with a subtype of hereditary spastic paraplegia called SPG61. Hereditary spastic paraplegia is a group of genetic disorders characterized by progressive weakness and stiffness in the lower limbs.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify genetic variations or mutations. It is a more comprehensive and efficient approach compared to traditional Sanger sequencing. NGS can be used to identify specific mutations in the ARL6IP1 gene that are associated with SPG61.

The NGS genetic test for ARL6IP1 gene SPG61 involves obtaining a DNA sample, typically through a blood sample or saliva sample, from the individual undergoing testing. The DNA sample is then sequenced using NGS technology to identify any variations or mutations in the ARL6IP1 gene.

The results of the NGS genetic test can provide valuable information about the presence or absence of specific mutations in the ARL6IP1 gene associated with SPG61. This information can help in confirming a diagnosis, providing accurate genetic counseling, and guiding treatment options for individuals with SPG61.